Answers are grounded in this paper and cite their sources.
Future clinical trials focusing on cancer immunotherapy will need to take into account the differences in the immune response and in the frequency of target antigen expression between male and females, in order to optimize these anti-cancer immunotherapies of the third millennium.
No takes yet. Share an insight, caveat, or question.
Mirandola et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: